Gamaleya Center submits documents for research into coronavirus vaccine for children

The Gamaleya Center has filed with the Russian Ministry of Health the documents for conducting clinical research into a coronavirus vaccine for children aged 6 to 11, the center’s director, Alexander Gintsburg, told journalists on Monday.

"This morning we submitted the documents for the children aged 6-11," Gintsburg said.

Earlier, the Russian Health Ministry has registered the Sputnik M coronavirus vaccine for children aged 12-17.